Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation

PI3K/AKT and RAF/MEK/ERK pathways are constitutively activated in Hodgkin lymphoma (HL) patients, thus representing attractive therapeutic targets. Here we report that the PI3K/ERK dual inhibitor AEZS-136 induced significant cell proliferation inhibition in L-540, SUP-HD1, KM-H2 and L-428 HL cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Locatelli, Silvia Laura, Careddu, Giuseppa, Stirparo, Giuliano Giuseppe, Castagna, Luca, Santoro, Armando, Carlo-Stella, Carmelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073341/
https://www.ncbi.nlm.nih.gov/pubmed/27767172
http://dx.doi.org/10.1038/srep35745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073341/
https://www.ncbi.nlm.nih.gov/pubmed/27767172
http://dx.doi.org/10.1038/srep35745

Ejemplares similares